The production of hemagglutinin-based virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza

Plant Biotechnology Journal

Volumn 8, Issue 5, 2010, Pages 607-619

  D'Aoust, Marc André ^a   Couture, Manon M J ^a   Charland, Nathalie ^a   Trépanier, Sonia ^a   Landry, Nathalie ^a   Ors, Frédéric ^a   Vézina, Louis P ^a  

^a Medicago Inc   (Canada)

Author keywords

Hemagglutinin; Influenza; Pandemic; Vaccine; Virus like particles

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

ANIMAL; BIOSYNTHESIS; EPIDEMIC; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; METABOLISM; REVIEW; TRANSGENIC PLANT;

ANIMALS; ANTIGENS, VIRAL; DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS;

AVES; MUS; MUSTELA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77953964469     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/j.1467-7652.2009.00496.x     Document Type: Review

References (58)

1. Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Müller M. Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol. 2003, 77:9211-9220.
2. Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Influenza virus-like particles elicit broader immune response than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007, 25:3871-3878.
3. Cardineau G, Mason HS, Vaneck JM, Kirk DD, Wamsley AM. Vectors and cells for preparing immunoprotective compositions derived from transgnic plants. 2004, International Patent application WO2004/0098533
4. Chen BJ, Leser GP, Morita E, Lamb RA. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 2007, 81:7111-7123.
5. U.S. Policy Regarding Pandemic-Influenza Vaccines. 2008, http://www.cbo.gov/ftpdocs/95xx/doc9573/09-15-PandemicFlu.pdf, Congressional Budget Office, URL [accessed on 27 August 2009]
6. D'Aoust M-A, Lavoie P-O, Couture MM-J, Trépanier S, Guay J-M, Dargis M, Mongrand S, Landry N, Ward BJ, Vézina L-P. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J. 2008, 6:930-940.
7. D'Aoust M-A, Couture M, Ors F, Trépanier S, Lavoie P-O, Dargis M, Vézina L-P. Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin. 2009, International Patent application WO2009/076778
8. Fernández-San Millán A, Ortigosa SM, Hervás-Stubbs S, Corral-Martínez P, Seguí-Simarro JM, Gaétan J, Coursaget P, Veramendi J. Human Papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol. J. 2008, 6:427-441.
9. Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, Gleba Y. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with non-competitive viral vectors. Proc. Nat. Acad. Sci. USA 2006, 103:14701-14706.
10. Gómez-Puertas P, Albo C, Pérez-Pastrana E, Vivo A, Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 2000, 74:11538-11547.
11. Greco R, Michel M, Guetard D, Cervantes-Gonzalez M, Pelucchi N, Wain-Hobson S, Sala F, Sala M. Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine 2007, 25:8228-8240.
12. Grgacic EVL, Anderson DA. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
13. Huang Z, Mason HS. Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. Plant Biotechnol. J. 2004, 2:241-249.
14. Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005, 23:1851-1858.
15. Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 2006, 24:2506-2513.
16. Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol. Bioeng. 2009, 103:706-714.
17. Kang S-M, Song J-M, Quan F-S, Compans RW. Influenza vaccines based on virus-like particles. Virus Res. 2009, 143:140-146.
18. Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letelier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A, Legocki AB. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 1999, 13:1796-1799.
19. Kendal AP, Pereira MS, Skehel J. Concepts and procedures for laboratory-based influenza surveillance 1982, Centers for Disease Control and Prevention and Pan American Health Organization, Atlanta, GA, B17-B35
20. Kilbourne ED. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006, http://www.cdc.gov/ncidod/EID/vol12no01/05-1254.htm, [serial on the Internet]. URL [Accessed on August 27, 2009]
21. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Nat. Acad. Sci. USA 2001, 98:11539-11544.
22. Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Lainé A-C, Gomord V, Faye L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 1998, 38:31-48.
23. Lico C, Mancini C, Italiani P, Betti C, Boraschi D, Benvenuto E, Baschieri S. Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine 2009, 27:5069-5076.
24. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson A-L, Rybicki EP. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J. Gen. Virol. 2007, 88:1460-1469.
25. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol. 2005, 23:718-723.
26. Mason HS, Man-Kit Lam D, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 1992, 89:11745-11749.
27. Mason HS, Ball JM, Shi J-J, Jiang X, Estes MK, Arntzen CJ. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA 1996, 93:5335-5340.
28. Mechtcheriakova IA, Eldarov MA, Nicholson L, Shanks M, Skryabin KG, Lomonossoff GP. The use of viral vectors to produce hepatitis B virus core particles in plants. J. Virol. Meth. 2006, 131:10-15.
29. Medicago's Avian flu pandemic vaccine achieves 100% protection in a lethal challenge study in ferrets. 2009, http://www.medicago.com/English/news/News-Releases/News-ReleaseDetails/2009/MedicagosAvianflupandemicvaccineachieves100protectioninalethalchallengestudyinferrets1120905/default.aspx, Medicago, URL [accessed on 27 August 2009]
30. Mena I, Vivo A, Pérez E, Portela A. Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. J. Virol. 1996, 70:5016-5024.
31. Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, Shoji Y, de la Rosa P, Palmer GA, Rabindran S, Streatfield SJ, Boyers A, Russel M, Mann A, Lambkin R, Oxford JS, Schild GC, Yusibov V. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respi. Viruses 2008, 2:33-40.
32. Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul A-M, Mett V, Rabindran S, Streatfield SJ, Yusibov V. A launch vector for the production of vaccine antigens in plants. Influenza and Other Respi. Viruses 2007, 1:19-25.
33. Nemchinov LG, Natilla A. Transient expression of the ectodomain of matrix 2 (M2e) of avian influenza A virus in plants. Prot. Expression and Purif. 2007, 56:153-159.
34. Vaccines for pandemic influenza A(H1N1). 2009, http://www.paho.org/English/AD/FCH/IM/QA_InfluenzaAH1N1_12Jul09_e.pdf, Pan American Health Organization, URL [accessed on 27 August 2009]
35. Rasochova L, Radam JM, Phelps JP, Dang N. 2007, Recombinant flu vaccines. International Patent application WO2007/0011904
36. Richter LJ, Thanaval Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 2000, 18:1167-1171.
37. Sainsbury F, Lomonossoff GP. Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol. 2008, 148:1212-1218.
38. Saint-Jore-Dupas C, Faye L, Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol. 2007, 25:317-323.
39. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen C, Chen Q, Mason HS. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26:1846-1854.
40. Séveno M, Bardor M, Paccalet T, Gomord V, Lerouge P, Faye L. Glycoprotein sialylation in plants? Nat. Biotechnol. 2004, 22:1351-1352.
41. Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, Yusibov V. Plant-expressed HA as seasonal influenza vaccine candidate. Vaccine 2008, 26:2930-2934.
42. Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, Mytle N, Ugulava N, Rabindran S, Mett V, Chichester JA, Yusibov V. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of influenza. Vaccine 2009a, 27:1087-1092.
43. Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, Chichester JA, Mett V, Yusibov V. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine 2009b, 27:3467-3470.
44. Smith ML, Mason HS, Shuler ML. Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol. Bioeng. 2002, 80:812-822.
45. Smith ML, Richter L, Arntzen CJ, Shuler ML, Mason HS. Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 2003, 21:4011-4021.
46. Spitsin S, Andrianov V, Pogrebnyak N, Smirnov Y, Borisjuk N, Portocarrero C, Veguilla V, Koprowski H, Golovkin M. Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine 2009, 27:1289-1292.
47. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune response to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 2000, 182:302-305.
48. Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Nat. Acad. Sci. USA 1995, 92:3358-3361.
49. Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M. Safety and immunogenicity of a bacculovirus-expressed hemagglutinin influenza vaccine. A randomized controlled trial. J. Am. Med. Assoc. 2007, 297:1577-1582.
50. Tsuda S, Yoshika K, Tanaka T, Iwata A, Yoshikawa A, Watanabe Y, Okada Y. Application of the human hepatitis B virus core antigen from transgenic tobacco for serological diagnosis. Vox Sang. 1998, 74:148-155.
51. Usha R, Rohll JB, Spall VE, Shanks M, Maule AJ, Johnson JE, Lomonossoff GP. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 1993, 197:366-374.
52. Varsani A, Williamson A-L, Rose RC, Jaffer M, Rybicki EP. Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch. Virol. 2003, 148:1771-1786.
53. Vézina LP, Faye L, Lerouge P, D'Aoust M-A, Marquet-Blouin E, Burel C, Lavoie P-O, Bardor M, Gomord V. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 2009, 7:442-455.
54. Warzecha H, Mason HS, Lane C, Tryggvesson A, Rybicki E, Williamson AL, Clements JD, Rose RC. Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol. 2003, 77:8702-8711.
55. WHO Manual on animal influenza diagnosis and surveillance. 2002, http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98-97937B4FA83C/0/manualonanimalaidiagnosisandsurveillance.pdf, World Health Organization, URL [accessed on August 27]
56. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection. 2009a, http://www.who.int/csr/disease/swineflu/notes/h1n1_surveillance_20090710/en/index.html, World Health Organization, URL [accessed on 27 August 2009]
57. Pandemic influenza vaccine manufacturing process and timeline. 2009b, http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/index.html, World Health Organization, URL [accessed on 27 August 2009]
58. Transcript of WHO Virtual Press Conference of 6 August 2009 with Dr Marie-Paule Kieny, Director of the Initiative for Vaccine Research at WHO Headquarters and Gregory Hartl, Spokesperson for H1N1. 2009c, http://www.who.int/mediacentre/pandemic_h1n1_presstranscript_2009_08_06.pdf, World Health Organization, URL [accessed on 27 August 2009]